S&P 500
(-1.01%) 5 064.54 points
Dow Jones
(-1.06%) 37 981 points
Nasdaq
(-1.22%) 15 787 points
Oil
(-1.42%) $81.46
Gas
(-2.07%) $1.988
Gold
(-2.12%) $2 307.80
Silver
(-3.54%) $26.68
Platinum
(-1.30%) $949.00
USD/EUR
(0.41%) $0.936
USD/NOK
(0.92%) $11.08
USD/GBP
(0.44%) $0.800
USD/RUB
(0.15%) $93.44

实时更新: Avadel Pharmaceuticals [AVDL]

交易所: NASDAQ 部门: Healthcare 工业: Drug Manufacturers—Specialty & Generic
Upcoming Earnings Alert

2 days till quarter result
(bmo 2024-05-02)

Expected move: +/- 12.23%

BUY
25.00%
return -1.92%
SELL
0.00%
return 3.33%
最后更新时间1 May 2024 @ 01:14

2.46% $ 18.41

出售 109601 min ago

@ $14.22

发出时间: 14 Feb 2024 @ 22:32


回报率: 29.48%


上一信号: Feb 13 - 22:30


上一信号: 购买


回报率: -0.21 %

Live Chart Being Loaded With Signals

Commentary (1 May 2024 @ 01:14):

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy...

Stats
今日成交量 435 421
平均成交量 1.19M
市值 1.87B
EPS $0 ( 2024-03-04 )
下一个收益日期 ( $-0.250 ) 2024-05-02
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -9.21
ATR14 $0.0300 (0.16%)
Insider Trading
Date Person Action Amount type
2024-02-20 Kim Richard J Buy 147 000 Stock Option (Right to Buy)
2024-02-20 Mchugh Thomas S Buy 157 500 Stock Option (Right to Buy)
2024-02-20 Divis Gregory J Buy 600 000 Stock Option (Right to Buy)
2024-01-16 Mchugh Thomas S Buy 2 000 ADSs
2023-12-28 Mccamish Mark Anthony Sell 75 000 ADSs
INSIDER POWER
81.01
Last 94 transactions
Buy: 6 417 800 | Sell: 317 647

音量 相关性

長: 0.12 (neutral)
短: 0.67 (moderate)
Signal:(32.64) Neutral

Avadel Pharmaceuticals 相关性

10 最正相关
HSKA0.968
ATRS0.958
LIQT0.946
ISEE0.944
XLRN0.94
BLU0.936
OVID0.934
CFIV0.933
MNST0.93
LABP0.93
10 最负相关
PEAR-0.951
MTEX-0.946
VYNT-0.944
NTGR-0.939
CFBK-0.937
HMST-0.931
VORB-0.93
INFN-0.929
AUB-0.927
EVBG-0.925

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Avadel Pharmaceuticals 相关性 - 货币/商品

The country flag 0.74
( moderate )
The country flag 0.82
( strong )
The country flag 0.00
( neutral )
The country flag 0.68
( moderate )
The country flag -0.25
( neutral )
The country flag -0.42
( neutral )

Avadel Pharmaceuticals 财务报表

Annual 2023
营收: $27.96M
毛利润: $25.35M (90.66 %)
EPS: $-2.00
FY 2023
营收: $27.96M
毛利润: $25.35M (90.66 %)
EPS: $-2.00
FY 2022
营收: $0
毛利润: $-1.49M (0.00 %)
EPS: $-2.29
FY 2021
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-1.320

Financial Reports:

No articles found.

Avadel Pharmaceuticals

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。